Sensus Healthcare director buys 34.7K shares

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported an open-market purchase of the company’s Common Stock.

Rhea-AI Filing Summary

Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported an open-market purchase of the company’s Common Stock. On 2026-08-24, he purchased 34,697 shares at a price of $3.254 per share, bringing his directly held position to 209,310 shares. He also reports 2,093 shares held indirectly through his spouse.

Insider Trade Summary

Net Buyer: 34,697 shares

Net Buy 2 txns

Insider Sachetta Eric

Role Director

Bought 34,697 shs ($113K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	34,697	$3.254	$113K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 209,310 shares (Direct); Common Stock — 2,093 shares (Indirect, Spouse)

Key Figures

Shares purchased: 34,697 shares Purchase price per share: $3.254 per share Direct holdings after transaction: 209,310 shares +2 more

5 metrics

Shares purchased 34,697 shares Common Stock purchase on 2026-08-24

Purchase price per share $3.254 per share Common Stock transaction on 2026-08-24

Direct holdings after transaction 209,310 shares Common Stock directly owned by Eric Sachetta after 2026-08-24 purchase

Indirect holdings (spouse) 2,093 shares Common Stock held indirectly through spouse

Net buy shares 34,697 shares Net buy direction per transaction summary

Key Terms

Common Stock, indirect ownership, Rule 10b5-1

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

indirect ownership financial

"ownership_type" : "indirect""

Rule 10b5-1 regulatory

"Footnotes may reference Rule 10b5-1 trading plans"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SRTS director Eric Sachetta report in this Form 4?

He reported a purchase of 34,697 shares of Sensus Healthcare, Inc. Common Stock on 2026-08-24 at $3.254 per share, increasing his directly held shares to 209,310 and reporting 2,093 additional shares held indirectly through his spouse.

How many SRTS shares did Eric Sachetta buy and at what price?

Eric Sachetta bought 34,697 SRTS shares of Common Stock at a price of $3.254 per share in a transaction dated 2026-08-24, described as a purchase in open market or private transaction.

What are Eric Sachetta’s total direct SRTS holdings after this transaction?

Following the reported purchase, Eric Sachetta’s direct holdings of Sensus Healthcare, Inc. Common Stock total 209,310 shares, according to the Form 4’s post-transaction ownership figure.

Does the Form 4 show any indirect SRTS ownership by Eric Sachetta?

Yes. The Form 4 lists an indirect holding of 2,093 SRTS shares categorized under “Spouse” as the nature of ownership, in addition to his directly owned shares.

Was this SRTS insider transaction under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan (aff_10b5_one is false), indicating the transaction is not reported as executed under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 09:27 AM Accepted by SEC EDGAR 08/25/2026 - 09:26 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last) (First) (Middle)

851 BROKEN SOUND PARKWAY NW #215

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/24/2026		P		34,697	A	$3.254	209,310	D
Common Stock								2,093	I	Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Eric Sachetta	08/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)